Enzyme protease

Fibrinolytic enzymes (proteases) are used to dissolve thrombus, the insoluble aggregate of fibrin and platelet including several additional cellular and molecular components of the blood. 

There are two main classes of proteolytic digestive enzymes (proteases), with different specificities for the amino acids forming the peptide bond to be hydrolyzed. Endopeptidases hydrolyze peptide bonds between specific amino acids throughout the molecule. They are the first enzymes to act, yielding a larger number of smaller fragments, eg, pepsin in the gastric juice and trypsin, chymotrypsin, and elastase secreted into the small intestine by the pancreas. Exopeptidases catalyze the hydrolysis of peptide bonds, one at a time, fi"om the ends of polypeptides. Carboxypeptidases, secreted in the pancreatic juice, release amino acids from rhe free carboxyl terminal, and aminopeptidases, secreted by the intestinal mucosal cells, release amino acids from the amino terminal. Dipeptides, which are not substrates for exopeptidases, are hydrolyzed in the brush border of intestinal mucosal cells by dipeptidases. 

Enzymes Proteases Various bacilli, e.g. Bacillus licheniformis... 

PV A film/ Sodium tetraborate/ Proteolytic enzyme Protease C (Pr)+ polyhexamethyleneguanidine hydrochloride [PHMG], as antimicrobial (AM) -biological active material -increases the AM desorption rateby 1.5-4.5 times For PHMG with M, 10000, total desorption of AM from the film could be obtained 236... 

PVA film/ Tetraborate (TB)/ Proteolytic enzyme Protease C (Pr)+, a cationic polymeric antimicrobial (AM=Metacid) 235... 

The pol gene, responsible for formation of viral enzymes protease, reverse transcriptase, and endonuclease (integrase). 

The clotting factors are protein molecules. Activation mostly means proteolysis (cleavage of protein fragments) and, with the exception of fibrin, conversion into protein-hydrolyzing enzymes (proteases). Some activated factors require the presence of phospholipids (PL) and Ca + for their proteolytic activity. Conceivably, Ca + ions cause the adhesion of factor to a phospholipid surface, as depicted in C. Phospholipids are contained in platelet factor 3 (PF3), which is released from ag-Lullmann, Color Atlas of Pharmacology 2000 Thieme All rights reserved. Usage subject to terms and conditions of license. 

The synthesis of a water-soluble diphenylmethano-bridged fullerene 122 was achieved by hydrolyzing the bis (acetamide) 121 with acetic acid-aqueous hydrochloric acid and then converting it into the bis(succinamide) 122 by treatment with succinic anhydride (Scheme 4.25) [158]. Compound 122 is soluble in water at pH > 7. This is an important requirement for the investigation of the biological activity of fullerenes. Remarkably, 122 is an inhibitor for the HIV enzymes protease (HIV-P) and reverse transcriptase (HIV-RT) [159]. As suggested by molecular modeling. 

Mechanism of Action Aprotease inhibitor combination drug in which lopinavir inhibits the activity of the enzyme protease late in the HIV replication process and ritonavir increases plasma levels of lopinavir. Therapeutic Effect Formation of immature, non-inf ectious viral particles. 

Previous studies have shown that muscle lysosomal hydrolases are released early in the postmortem period due to a decrease in intracellular ATP concentrations. The decreased intracellular ATP level causes the rupture of the lysosomal membrane (14), releasing hydrolytic enzymes (proteases, lipases, and glycosidases) that further potentiate the weakening of membrane integrity and cellular function. Furthermore, as the acidosis increases (due to the anaerobic conditions associated with cellular death) the intramuscular pH to levels reach that which are optimal for the activity of several lysosomal thiol proteinases. 

Figure 8.15 Cartoon showing how proteins, polysaccharides and surfactants (emulsifiers) might be distributed at the triglyceride-water interface. Inter-facial complexation in vivo between adsorbed protein and charged polysaccharide in the gastrointestinal tract could affect digestion of protein and fat by forming structures that inhibit the accessibility and activity of enzymes (proteases and lipases). Reproduced from Dickinson (2008) with permission.

If St. John s wort can alter levels of cyclosporin in the blood, might it not also interfere with the action of other medications Recent research indicates that it can. Not surprisingly, the affected drugs are those that, like cyclosporin, are also metabolized by cytochrome enzymes. Protease inhibitors, used in the treatment of hiv infections, are a prime example. Because of the popularity of St. John s wort as an antidepressant and the incidence of depression in patients diagnosed with HIV infections, researchers at the U.S. National Institutes of Health decided to investigate the consequences of using the herbal remedy and the protease inhibitor indinavir concurrently. Doctors prescribe indinavir to prevent the hiv virus... 

Class of drugs designed to inhibit the enzyme protease. 

For some enzymes, an inactive precursor called a zymogen is cleaved to form the active enzyme. Many proteolytic enzymes (proteases) of the stomach and pancreas are regulated in this way. Chymotrypsin and trypsin are initially synthesized as chymotrypsinogen and trypsinogen (Fig. 6-33). Specific cleavage causes conformational changes that expose the enzyme active site. Because this type of activation is irreversible, other... 

Substrate specificity. Like most other enzymes, proteases display distinct preferences for certain substrates. These are often discussed using the nomenclature of Fig. 12-14. The substrate residue contributing the carbonyl of the amide group to be cleaved is designated Pj and residues toward the N terminus as P2, P3, etc., as is shown in Fig. 12-14. Residues toward the C terminus from the peptide linkage to be cleaved are designated P P etc. Chymotrypsin acts... 

Many biological cells contain degradative enzymes (proteases) that catalyze the hydrolysis of peptide linkages. In the intact cell, functional proteins are protected from these destructive enzymes because the enzymes are stored in cell organelles (lysosomes, etc.) and released only when needed. The proteases are freed upon cell disruption and immediately begin to catalyze the degradation of protein material. This detrimental action can be slowed by the addition of specific protease inhibitors such as phenylmethyl-sulfonyl fluoride or certain bioactive peptides. These inhibitors are to be used with extreme caution because they are potentially toxic. 

In the life cycle of HIV, its RNA is translated into a polypeptide chain that is composed of several individual proteins including protease, integrase and reverse transcriptase, but in this form these enzymes are not functional. They must be cleaved by viral proteases from the assembled sequence in order for them to become functional. These posttranslational modifications allow the enzymes to facilitate the production of new viruses. The protease itself is made up of two 99-amino-acid monomers, and an aspartic acid residue in the monomer is required for the cleavage. The protease inhibitors inhibit the enzyme protease and consequently interfere with viral replication and maturation by preventing proteases from cleaving proteins into peptides. In humans, these drugs inhibit cleavage of HIV gag and pol polyproteins, which are part of the essential viral structural components, P7, P9, P17 and P24, and... 

Between the cited enzymes, proteases represent the prominent barrier for the absorption of peptides and proteins into the systemic circulation [5,6,10]. 

---